INTRODUCTION {#cesec10}
============

Infectious bronchitis (**IB**) is a disease caused by the IB virus (**IBV**), a member of the Gammacoronavirus genus, the *Coronaviridae* family, and the Nidovirales order (International Committee on Taxonomy of Viruses, [@bib19]). IB has a significant economic impact with production losses related to poor weight gains, condemnation at processing and mortality in broilers, suboptimal egg production and egg downgrading in laying birds (Cook et al., [@bib13]). Despite the applied intensive vaccination programs, outbreaks re-emerge as a consequence of infections with new variants that differ serologically from the strains used for vaccination (Chen et al., [@bib10]; Leghari et al., [@bib21]; Feng et al., [@bib17]). Besides, in the absence of a "standard" vaccination program against IB, the program recommended by the National Committee for Avian Pathology (NCAP) remains an alternative to prevent avian disease infections. Unfortunately, it appears that there are programs as breeding as reported by Cherif et al. ([@bib12]). This largely explains the variability of protection outcomes and the sustainability of the disease, despite the availability of the latest generation of vaccines.

The IBV genome consists of a single-stranded positive-sense RNA molecule of approximately 27.6 kb, which encodes several nonstructural proteins involved in RNA transcription and replication and four structural proteins, known as small membrane (**E**), membrane (**M**), nucleoprotein (**N**), and spike glycoprotein (**S**) (Boursnell et al., [@bib6]), which is formed by a globular (S1) subunit that is anchored in the membrane by the S2 subunit (Cavanagh, [@bib9]). The S1 subunit is the major target for neutralizing antibodies and carries serotype-specific antigenic determinants (Liu et al., [@bib22]). In addition to these roles, recently it was reported that *S* and 5a accessory gene are responsible for the attenuation of virulent IBV strains (Zhao et al., [@bib33]). The genome of IBV includes the untranslated regions (**UTR**) at the 5′ and 3′ genome regions, which play a role in RNA synthesis (Sawicki et al., [@bib27]) and classification of IBV (Hewson et al., [@bib18]). The 3′-UTR is involved in the initiation of negative-strand RNA synthesis and has also been used to assess variations in emerging IBV strains and other members of coronavirus group 3 (Williams et al., [@bib31]; Breslin et al., [@bib7]).

In fact, IBV genotype may differ by up to 50% of the amino acids sequences of their S1 proteins (Sjaak de Wit et al., [@bib29]); such variations have led to the emergence of new serotypes; for this, the *S1* gene nucleotide sequence is being widely used for phylogenetic classification of IBV, especially the hypervariable regions HVR1, HVR2, and HVR3.

The emergence of variant strains may be related to extensive nucleotide and deduced amino acid sequence variabilities in the IBV genome, which are often responsible for IB outbreaks in vaccinated flocks (Liu et al., [@bib22]; Roussan et al., [@bib26]). The main aim of this study was to perform molecular characterization of Tunisian IBV isolates, based on the *S1* gene compared to the 3′-UTR region.

MATERIALS AND METHODS {#cesec20}
=====================

Study Population and Sample Collection {#cesec30}
--------------------------------------

Samples were collected from commercial broilers of a flock housing 1,500 birds in the Eastern region of Tunisia (Nabeul), a major Tunisian industrial poultry region. They were aged 4 to 5 wk old, and showing respiratory symptoms. Tracheal and cloacal swabs were randomly collected from 10 live birds and separately pooled. Internal organs including liver, lungs, spleen, and tonsils were collected from eight necropsied birds. All chickens were previously vaccinated in the hatchery at 1 D old with a commercial IB Mass vaccine strain (**H120**) by spray and no samples from healthy animals were collected. All samples were brought to the Laboratory of Epidemiology and Veterinary Microbiology for diagnosis in the frame of the 2016 national surveillance program of myxoviruses. Organs were washed with PBS then grinded in presence of sterile Minimum Essential Media containing 5% antibiotics before centrifugation at 1500 rpm for 15 min at +4°C. Supernatants of grinded organs and swab samples were collected under sterile conditions. The virus suspension was then filtered through a 0.45 μm Millipore filter to avoid any bacterial contamination, divided into aliquots, and stored at −80°C.

Virus Isolation {#cesec40}
---------------

A 0.2 ml volume of inoculum of pooled internal organs of each 1 of the 8 birds as well as the supernatants of tracheal and cloacal swabs of the pooled 10 live birds, were inoculated into the allantoic cavity of 11-day-old embryonated specific pathogen-free (**SPF**) hen eggs for amplification; 3 eggs were used for each sample. A maximum of 1 embryonated egg passage was used. After 48 to 72 h incubation period, the eggs were chilled and the allantoic fluids were harvested and specific embryonic lesions and mortalities were recorded. Collected allantoic fluids, organ, and swabs supernatants were then tested using a real time polymerase chain reaction (**PCR**), after virus RNA extraction.

RNA Extraction {#cesec50}
--------------

Supernatants of grinded organs and swab samples as well as allantoic fluids of inoculated embryonated eggs were centrifuged at 12,000 rpm for 5 min at 4°C. The various collected supernatants (0.3 ml) were mixed with 1.0 ml TRIzol reagent (Invitrogen, Carlsbad, CA, USA), The lysates were then incubated at room temperature for 10 min to allow complete dissociation of the nucleoprotein complexes; and then, 0.2 ml chloroform was added and the mixtures were shaken vigorously for 15 s, followed by centrifugation at 12,000 rpm for 15 min at 4°C. The upper aqueous phase was carefully taken out into another microfuge tube and 0.8 ml isopropanol was added to precipitate total RNA. The extracted RNA was kept at −20°C overnight then taken out and centrifuged at 12,000 rpm for 30 min to pellet the RNA. After washing with 70% ethanol, the dried RNA pellet was dissolved in 20 μl RNase-free water and stored at −80°C until use.

Detection of IBV by REAL-TIME RT-PCR Assay {#cesec60}
------------------------------------------

TaqMan real-time RT-PCR was performed to detect conserved (5′-UTR) region of IBV using AgPath-ID™ One-Step RT-PCR Kit Mix (Applied Biosystems) and specific primers and probes previously described by Callison et al. ([@bib8]). The cycling conditions for the quantitative RT-PCR were as follows: 1 cycle of 45°C for 10 min (reverse transcription), 95°C for 15 min (RT inactivation and activation of the AmpliTaq Gold DNA polymerase), and 40 cycles of 95°C for 15 s and 60°C for 1 min (annealing, extension step, and fluorescence data collection).

Detection of IBV by Conventional PCR Assay {#cesec70}
------------------------------------------

The 3′-UTR region and the *S1 gene* were amplified for each isolate using primers reported previously (McFarlane and Verma, [@bib24]; Hewson et al., [@bib18]). One-step RT-PCR was performed using EasyScript One-Step RT-PCR (TransGen Biotech) that combines the first-strand cDNA synthesis with PCR reagents in the same tube to simplify reaction set-up and reduce any contamination. About 50 ng to 5 μg of total RNA of each sample were reverse transcribed at 45°C for 30 min and stopped at 94°C for 5 min followed by 36 cycles at 94°C for 30 s, 55°C/49°C for 30 s for the 3′-UTR and the *S1 gene*, respectively and then 72°C for 3 min, and a final extension at 72°C for 10 min. The PCR products were separated on 2 and 1% agarose gel and identified by ethidium bromide staining.

Sequencing of Partial S1 Gene and 3 UTR Region {#cesec80}
----------------------------------------------

The RT-PCR amplification products of S1-targeted gene were purified from the agarose gel using Easy Pure Genomic DNA Kit (TransGen Biotech). The PCR products were purified with shrimp alkaline phosphatase and exonuclease I to remove the excess dNTPs and primers as follows by adding 0.5 μl exonuclease I (20U/μl) and 0.5 μl shrimp alkaline phosphatase (1 U/μl) to each PCR sample (5 μl) in a final volume reaction of 10 μl and incubating in the thermal cycler at 37°C for 15 min then in 80°C for 15 min to inactivate the enzymes. Purified DNA was then sequenced using the BigDye Terminator version 3.1 Cycle Sequencing Kit that contains thermally stable AmpliTaq DNA polymerase, modified dNTPs, and a set of dye terminators labeled with high-senility dyes. The sequencing reaction was prepared as follows: 10 μl PCR product of each gene, 2 μl BigDye sequencing mix, 4 μl Buffer 5X, 1 μl of specific primer (10 μM), and 4 μl RNase-free H~2~ O. The sequencing program consisted of a pre-denaturation step at 96°C for 3 min followed by 25 cycles of 10 s denaturation at 96°C, 5 s annealing at 50°C, and 150 s elongation at 60°C. Overlapping DNA fragments were sequenced in both directions from 2 independent PCRs to generate a consensus sequence for each isolate. The finished sequencing reactions were washed with 50 μl of 80% ethanol, centrifuged at 13,000 rpm for 15 min, and dried at room temperature. The DNA was then resuspended in 20 μl RNase-free water. Sequencing reactions were run and analyzed in an ABI PRISM 3500 Genetic Analyzer (Applied Biosystems).

Phylogenetic Analysis {#cesec90}
---------------------

The quality of the obtained sequences was analyzed by BioEdit (version 7.2.5.0), and the sequence similarity was checked against sequences deposited in GenBank using a BLAST search at the National Center for Biotechnology Information (NCBI) site (<http://www.ncbi.nlm.nih.gov>). The ClustalW was used for sequence alignment and the phylogenetic trees were constructed with MEGA7 using the Neighbor-Joining method with 1,000 bootstrap replicates to assign confidence levels to branches. The obtained sequences of isolated virus were submitted to GenBank. For the analysis of recombination events, the RDP package v.4 software was used.

RESULTS {#cesec100}
=======

Clinical and Necropsy Findings {#cesec110}
------------------------------

The birds of the suspected broiler flock have shown clinical signs characteristic of IB including gasping, coughing, tracheal rales, and nasal discharge. Mortality was about 60% following secondary *Escherichia coli* infections confirmed with the Api 20E system. Necropsy revealed increased tracheal mucus, tracheitis with congested lung, slight congestion and airsacculitis, catarrhal exudates in the nasal turbinate.

Virus Isolation {#cesec120}
---------------

After the first passage in the allantoic cavity of embryonated SPF hen eggs, all inoculated embryos were dead between 48 and 72 h postinfection and showed hemorrhages and developed stunting, curling, and dwarfing, characteristic lesions of IBV infection.

Real Time and Conventional PCR for IBV Detection {#cesec130}
------------------------------------------------

Real time PCR was performed on the extracts from each collected organ of necropsied birds, pooled swabs of live birds and allantoic fluids. They were all shown positive with cycle threshold ranging from 15 to 31. No other viral respiratory infections such as avian influenza, metapneumovirus, and Newcastle diseases were detected, indicating the absence of any co-infection.

Out of all the tested extracts, only allantoic fluids of 2 (TN1011/16 and TN 1012/16) out 8 inoculated grinded supernatants were amplified by conventional PCR for both *S1 gene* and 3\'UTR region. Positive amplification bands of 1,700 pb of *S1 gene* and 433 pb of 3'UTR region were visualized.

Analysis of Partial Sequences of S1 Gene and 3′ UTR Region {#cesec140}
----------------------------------------------------------

The obtained sequences of the 3′-UTR region and the *S1 gene* of TN1011/16 and TN1012/16 were submitted to GenBank under accession numbers KX290460, KX290461 and KX061458, KX061459, respectively.

To establish the phylogenetic relationships between these Tunisian isolates and 137 IBV reference strains, representative of 6 described genotypes, the standardized method elaborated by Valastro et al. ([@bib30]) was followed. Their partial sequences of *S1 gene* (800pb) were retrieved from GenBank and were compared to both isolates TN1011/16 and TN1012/16.

The results of sequenced *S1 gene* of the Tunisian isolates TN1011/16 and TN1012/16 showed 98.7% and 97% nucleotide and amino acid identities, respectively. Comparison of the partial *S1 gene* sequences showed that nucleotide identities between both TN1011/16 and TN1012/16 isolates with referenced IBV strains, ranged from 56.8 to 93%. Indeed, the TN1011/16 and TN1012/16 isolates showed the highest nucleotide sequence identity (92.8, 93.1, and 93.3%) with the Algerian strains: Algeria/26/b1 (KP892759), Algeria/26/b2 (KP892760), and Algeria/26/b3 (KP892761), respectively. Unexpectedly, the lowest nucleotide sequence identity was shown with the old Tunisian strain TN20/00 (56.8%), isolated in the year 2000.

Similarly, the S1 amino acid sequences analysis of TN1011/16 and TN1012/16 revealed its close relatedness to the Algerian strains. In fact, these 2 isolates showed the highest identity to Algeria/26/b1, Algeria/26/b2, and Algeria/26/b3 strains with 88.1, 88.1, and 89% amino acid sequence identities, respectively.

On the other hand, nucleotide identities between TN1011/16 and TN1012/16 strains and either the H120 (KF188436) or the 4/91 vaccine strains (KF377577) were either 78.6 and 78.5% or 74.9 and 74.5%, respectively. Furthermore, comparative analysis of their deduced amino acid sequences showed that they do not exceed 71.7 or 70.2% of identity, respectively.

Comparisons of *S1 gene* sequences of TN1011/16 and TN1012/16 showed differences in nucleotide and amino acid sequences with other reported strains. Specific mutations were shown for TN1011/16 and TN1012/16 and located in or nearly the hypervariable regions (HVR1 and HVR2), having close relationship with neutralizing epitopes. It was shown that DR-H and DR-P motifs between positions 14 and 17 were detected only in TN1011/16 and TN1012/16, and were different from all reference strains. Other mutations, specific to TN1011/16 and TN1012/16 were also found at positions ^97^ Q,^202^ R, and ^272^ G of S1 amino acid sequences.

The TN1011/16 isolate presented three specific differences in its amino acid sequence at positions^250^ F, ^262^ W, and^281^ G compared to all other strains. Besides, multiple amino acid sequence alignment of *S1 gene* revealed specific mutations within the genome of TN1012/16 strain at positions^262^ C,^265^ S,^266^ I, and ^284^ F, which are not found in any other IBV strains. With regard to the comparison of TN1011/16 and TN1012/16 with the Algerian strains, 5 common mutations in the amino acid sequences of the S1 glycoprotein were observed at positions ^4^ Q, ^51^ I,^153^ G, ^207^ S, and ^244^ K (Figure [1](#fig1){ref-type="fig"} ).Figure 1Amino acid sequence alignment of the partial S1 glycoprotein gene. Sequences were aligned using the BioEdit program. The parameter for pairwise alignment was BLOSUM62 similarity matrix. The specific residues to TN1011/16 are boxed in green. The specific residues to TN1012/16 are boxed in blue. The identical residues of TN1011/16 and TN1012/16 are boxed in red. The identical residues to Algeria/26/b1, Algeria/26/b2, and Algeria/26/b3 are boxed in black.

Phylogenetic Analysis {#cesec150}
---------------------

The constructed phylogenetic tree deduced from the nucleotide sequences of the partial S1 glycoprotein *gene* of the Tunisian isolates (Figure [2](#fig2){ref-type="fig"} ) showed that they form a commun branch with the 3 Algerian IBV strains but clearly clustered into two distinct subgroups within the GI genotype. The sequence analysis of the partial *S1 gene* demonstrated that the Tunisian isolates represent a unique genotype as compared to other reference strains from various countries and clearly related to the Algerian strains with a high bootstrap value.Figure 2Phylogenetic tree of IBV based on the alignment of the nucleotide sequences of the *S1* gene. Sequences were aligned using ClustalW with default settings in BioEdit (version 7.2.5.0). The phylogenetic tree was constructed by the Neighbor-Joining method with 1,000 bootstrap replicates using MEGA7. Tunisian isolates are marked in red square.

The phylogenetic tree allowed confirmation of the presence of unique variant of IBV circulating in Tunisia in 2016. According to the new proposed classification (Valastro et al., [@bib30]), the generated phylogenetic tree showed the presence of 6 genotypes (**GI-GVI**) with 28 lineages into genotype I (GI), which contains the majority of IBV strains. Besides, 5 genotypes (GII-GVI) contain 1 lineage each and a number of unique variants that do not belong to any lineage (Valastro et al., [@bib30]). The TN1011/16 and TN1012/16 isolates have not been grouped within any lineage and each one represents a unique variant. However, they may be grouped with the three Algerian strains since they share the highest nucleotide and amino acid identities. They are distant from the Tunisian strain isolated in 2000 (TN 20/00), which belongs to lineage 14 in GI. The Tunisian and the Algerian strains do not form a lineage yet since they were isolated from only two outbreaks (Valastro et al., [@bib30]).

Using the RDP package v.4 software, developed by Martin et al. ([@bib23]), which identifies and characterizes individual recombination events, it was shown that no recombination events has occurred between the TN1011/16 and TN1012/16 isolates as compared to different sequences in the GeneBank database. This result supports the novelty of the strains by showing the absence of probable positions of break and recombination points. However, data analysis of the old Tunisian isolate TN20/00, showed that it is a recombinant strain with probable positions of breakpoint and recombination events at 583 and 612. Besides, its sequences came from the recombination of the major parent Alabama/10,902/97 (AF510334) with 76.4% similarity and the minor parent Spain/99/319 (DQ064810).

With regard to the 3′UTR, the nucleotide sequences of TN1011/16 and TN1012/16 isolates were aligned and compared to 16 representative 3′UTR strains, available in the GenBank, from the same reference strains used for the *S1 gene* classification. It appeared that the 3′UTR nucleotide sequences of both isolates were closely related to the 4/91 vaccine (KF377577) and the Ck/CH/LSD/110,857 (KP118885) strain, with 97.67 and 97.4% nucleotide identities respectively; such results were contrary to those obtained with the alignment of *S1 gene*. Unfortunately, the 3′UTR region was not sequenced for the Algerian strains showing highest sequence similarity based on the *S1 gene*. Moreover, the multiple nucleotide sequence alignment of the 3′UTR of TN1011/16 and TN1012/16 strains with all sequences available in GenBank revealed 2 new mutations ^19^ A and ^117^ C that have not been previously reported. Thus, the phylogenetic tree based on the 3\'UTR region showed a completely different result with that obtained using the *S1 gene*. Indeed, GV and GI genotypes were grouped as one genotype. On the other hand, TN1011/16 and TN1012/16 strains were grouped in the lineage 13 within genotype I (GI-13) whereas they were classified as single variantwithin genotype I (GI) using the *S1 gene* (Figure [2](#fig2){ref-type="fig"}).

DISCUSSION {#cesec160}
==========

The IBV has long emerged worldwide with several genotypes, serotypes and variants with no consistent basis for its classification. Recently, the study of Valastro et al. ([@bib30]) proposed a phylogenetic method that harmonizes the classification of IBV based on the *S1 gene* either in its entirety or through the hypervariable regions HVR1 and HVR2. Several new variants and genotypes have been identified in recent years. Very recently Chen et al. ([@bib11]) have identified a new lineage (**GI-28**) within the genotype I (**GI**) confirming the emergence of new genotypes and variants throughout the world. In this study, circulating IBV strains, in Tunisia, were examined to determine their genotype in comparison with 137 sequences of reference strains, representative of 6 described genotypes. The Tunisian isolates TN1011/16 and TN1012/16 have shown a distinct molecular background as compared to other genotypes and have been included in a new branch along with the Algerian strains with which they share the highest percentage of nucleotide identity (79.9%).

Based on the study of Valastro et al. ([@bib30]), which states that a genotype is defined only if a new branch appears and is composed of isolated strains from at least 3 different outbreaks. Since both Algerian and Tunisian isolates stemming from only 2 different outbreaks, our reported isolates were designated new unique variant. We notice that Tunisia is surrounded by countries where different genotypes that are quite distant from our isolates, most of which are of genotype G1-23, which includes Israelian and Egyptian variants (Even-Chen et al., [@bib14]; Abdel-Sabour et al., [@bib1]) as well as Turkish and Libyan variants that have been identified in 2011 and 2012, respectively (Kahya et al., [@bib20]; Awad et al., [@bib2]; Yilmaz et al., [@bib32]). In Morocco, continuous monitoring of the IBV spread has shown the emergence of Italy 02 genotype, co-circulating with both Massachusetts and 4/91 serotypes clustered in the G1-21, G1-1, and G1-13, respectively (Fellahi et al., [@bib15]; [@bib16]), while Spanish IBV strains belong to the QX genotype (G1-19) (Moreno et al., [@bib25]).

The present study confirms that new unique variant belonging to group I (GI) are represented by the 2 new IBV strains isolated in Tunisia, in 2016. The TN1011/16 and TN1012/16 strains were identified in broiler chickens suffering from severe respiratory distresses, using real-time RT-PCR. They were genotyped using the *S1 gene* and the 3′UTR region sequence analyses. The alignment of the S1 sequences of both Tunisian isolates along with 137 referenced IBV strains revealed a high homology and a close relationship with the Algerian strains, isolated in 2012 and 2013, but not with the old Tunisian variant isolated during 2000 to 2007 (Bourogâa et al., [@bib3]; Sid et al., [@bib28]). Indeed, the first characterization of IBV in Tunisia has described a novel variant, serologically, very distant from the Mass H120 vaccine strain but closely related to CR88121 and D274 (Bourogâa et al., [@bib3], [@bib4]). Between 2007 and 2010, other IBV variants have emerged showing between 50 and 77% similarities with variants isolated in 2000 and 2001 (Bourogâa et al., [@bib5]).

In 2012, following variations in serotypes of IBV circulating in Tunisian flocks, combining CR88 (793B) with H120 (Mass type) vaccines was included in the natural vaccination program against IBV, for better protection. Indeed, Bourogaa et al. ([@bib4]) conducted experimental trials to evaluate tracheal and renal cross protection in chickens vaccinated by oculo-nasal instillation. The results showed a weak protection when H120 strain was used alone. There were no reduction in tracheal and kidney damage after a challenge with the strain TN20/00. On the other hand, the combination of heterologous serotypes, based on the vaccine strains (H120) and CR88, allowed a higher protection. Thus, a vaccination protocol that combines CR88 with H120 has since been applied. The following years, the variant strain 4/91 has been also introduced.

The results obtained when using the 3′UTR sequences for the classification of the TN1011/16 and TN1012/16, isolates did not correlate with those obtained when using the *S1 gene* sequences. Phylogenetic analysis used to compare the nucleotide sequences of TN1011/16 and TN1012/16 with other reported strains revealed different clustering depending on whether the *S1* gene or the 3′UTR is used for such analysis. Our results did not correlate with those of Hewson et al. ([@bib18]) who have found strong inter-strain correlation between the *S1 gene* and the hypervariable region in the 3′UTR and proposed the use of the 3′UTR for IBV strain differentiation. Williams et al. ([@bib31]) found that the 3′UTR contains a hypervariable region that may vary from 53 to 92.8% between IBV strains and may also be absent in other strains such as Mass 41 strain.

The comparison of the 3′UTR nucleotide sequences of TN1011/16 and TN1012/16 to that of 16 representative strains showed different results from those found with the *S1 gene* analysis. It is concluded that phylogenetic classification, using the 3\'UTR region, does not correlate with that of the *S1 gene*, in particular with the new classification of IBV proposed by Valastro et al. ([@bib30]). For this reason, it is not recommended to use 3\'UTR region in this regard.

Besides, the phylogenetic relationships of TN1011/16 and TN1012/16 strains with vaccine strains commonly used in Tunisia were evaluated. Indeed, the IBV H120 and 4/91 live attenuated vaccine strains; shared low similarities with the newly characterized strains and classified in fairly distant groups based on phylogenetic analysis of the *S1 gene* sequences. On the other hand, when phylogenetic analysis was based on the 3′UTR sequences, the attenuated vaccine strain 4/91 seemed to be closer to the new TN1011/16 and TN1012/16 strains.

The vaccine strains H120 and 4/91 currently used in Tunisia are classified in lineages GI-1 and GI-13 within genotype I, respectively. It is then clear that the new variants TN1011/16 and TN1012/16 are quite distant from these vaccine strains. Besides, Sid et al. ([@bib28]) have also reported that the Algerian strains are different from the new 4/91 strain and the commonly H120 strain used for a long time in the field.

The results trigger serious concerns about the efficacy of the vaccines used at this time in Tunisia (H120 at day old and 4/91 at 10 to 14 D as boosters). This newly proposed classification will help to facilitate monitoring and classification of newly emerged strains of IBV through epidemiological studies aimed at understanding and controlling the newly characterized. Tunisian isolates, shown to be new variants of IBV, highlighted the mutations detected in *S1 gene* and 3′UTR region.

Such classification would bring information about the genetic background necessary for the control and the surveillance of the disease. This result can be strongly supported by serological tests confirming the emergence of new serotypes. In vivo tests will also be useful to determine the pathogenicity of these strains and to test the efficacy of the H120 and 4/91 vaccines currently used against these strains.
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